Introduction: Bariatric surgery may lead to unsatisfactory weight loss, weight loss plateau, and even weight regain after various types of surgery. Despite the numerous studies, the mid-term results of surgery, after repetitive weight fluctuations remain a major concern. The aim of the present study was to determine the key time points of weight changes after three types of bariatric procedures, as well as to determine 5-year weight loss outcome after surgery. Methods: This is a retrospective cohort study including patients with morbid obesity conducted in the Minimally Invasive Surgery Research Center. The patients underwent one of the three types of bariatric surgeries including laparoscopic sleeve gastrectomy (LSG), Roux-en-Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB), who had been followed up for weight loss trend during 5 years postoperatively. Results: The mean excessive weight loss (%EWL) and total weight loss (%TWL) of 2,567 participants with obesity (mean age = 39.03, mean BMI = 45.67) in the first 6 months after surgery was independent of the type of surgery (p > 0.05). OAGB and RYGB showed significantly higher weight loss compared to LSG in ninth and 24th month after surgery, respectively (p < 0.05). The 5 years %WL could be comparable with %WL in 6, 9, and 12 months after LSG, RYGB, and OAGB, respectively. Conclusion: OAGB provides the fastest and highest %EWL and %TWL, while LSG induced the earliest and largest weight plateau and weight regain during 5-years post-surgery. The pattern of early weight loss could predict the mid-term outcome of bariatric surgery. So, early identification of suboptimal weight loss could enhance long-term weight loss.

Bariatric surgery is recognized as the most effective long-term treatment of morbid obesity [1‒3]. Several factors such as age, gender, genetic, obesity phenotype, lifestyle factors, as well as the type of bariatric surgery influence the percentage weight loss after surgery [4]. Laparoscopic sleeve gastrectomy (LSG), Roux-en-Y gastric bypass (RYGB), and more recently one-anastomosis gastric bypass (OAGB) have been the most popular and bariatric operations in recent years, resulting in different weight loss at different times post-surgery [5].

Recent studies have reported that bariatric surgery may lead to unsatisfactory weight loss, weight loss plateau, and even weight regain after surgery which could occur at different times after various types of surgery in each person [6, 7]. In spite of numerous studies exploring the trend and amount of bariatric surgery-induced weight loss, the mid-, and/or long-term outcome of surgery remains one of the most important concerns. Understanding the key times which is most probable to hit in weight loss plateau or weight regain in various types of surgery could be a contribution to preventive planning. Further, determining the amount and time of maximum possible weight loss, particularly in the longer term helps surgeons consider the most suitable type of surgery based on patients’ weight goal and make reasonable expectations about the surgery for patients. Thus, the main aim of the present study was to determine the key time points of attaining maximum weight loss, weight loss plateau, and weight regain after three types of bariatric surgery as well as to determine the mid-term weight loss outcome 5 years after various types of bariatric surgery.

Study Design, Setting, and Participants

This is a retrospective cohort study conducted in the obesity clinic of Minimally Invasive Surgery Research Center. The participants were patients with morbid obesity (BMI ≥40 and/or BMI ≥35 with more than one obesity-related comorbidities had undergone various types of bariatric procedures. The data used in this study have been obtained from the National Obesity Surgery Registry Database from March 2016 to May 2022. We included cases that had undergone one of the three types of bariatric procedures consisting of OAGB, RYGB, or LSG and had been followed up to 5 years post-surgery. The patients with conditions including post-surgery pregnancy as well as the patients with secondary obesity caused by endocrine disorders and patients with major psychiatric disorders were excluded from the analysis. The present project was approved by the Ethics Committee of Iran University of Medical Sciences with the ID number of IR.IUMS.REC 1395.95-04-140-29239.

Variables and Data Sources/Measurement

One surgeon had done all operations. Procedure selection by the surgeon was based on patient’s age, sex, body weight, BMI, obesity comorbidities specially T2DM, endoscopic evaluation results, dietary patterns/habits (volume eating or grazing, etc.), efficacy of each procedure in weight loss, and even functional status, social supports of patients.

The weight loss outcome of bariatric surgery was evaluated as excessive weight loss (%EWL) and total weight loss (%TWL) which has been defined according to the following formula. The ideal body weight was calculated based on height and BMI = 25.

%EWL = (initial weight − postoperative weight)/(initial weight − ideal weight) × 100

%TWL = (initial weight − postoperative weight)/(initial weight) × 100

The weight regain was determined as a reduction of mean %EWL from the maximum %EWL [8]. For measuring the weight (by SECA 711 scale, Medical Measuring Systems, and Scales Factory, USA), the participants were asked to remove the heavy clothes and shoes. Their height was read while the back of the head, shoulder blades, buttocks, and heels touched the stadiometer.

Some comorbidities including impaired glucose tolerance (IGT.ei 100< FBS <125), T2DM (ei FBS ≥126), dyslipidemia, and hypothyroidism were assessed using the pre-surgery laboratory tests. Further, the history of hypertension, sleep apnea, cardiovascular disease, as well as low-back and knee pain were diagnosed and recorded by physicians. Some variables including lifestyle and socioeconomic factors, dietary pattern, smoking, alcohol or substance abuse, psychiatric or emotional status, and physical activity, which were unavailable for evaluation in this study, may play as potential confounder variable and could affect the weight loss outcomes.

Study Size and Statistical Methods

To obtain a more robust analysis, we include data from all 2,567 patients available from the database. The quantitative variables were expressed as mean±SD where qualitative factors were presented as number and percentage. Statistical tests including repeated measurement analysis, one-way ANOVA, Kruskal Wallis H, and χ2 were conducted by SPSS software (version.22). The effect of baseline differences was adjusted using ANCOVA. The post-hoc Tukey’s HSD test was conducted to confirm power analysis. Tukey’s HSD test compares the difference between each pair of surgery types group means to determine which differences are large enough to be considered significant. A p value lower than 0.05 was considered significant.

Participants and Descriptive Data

The participants of the present study were a total of 2,567 with morbid obesity who had undergone three types of bariatric surgery. The percentage of loss to follow-up was 34% until 5-year after surgery. The mean age of patients was 39.03 ± 26 which was not significantly different between operations. Most participants were women (80.1%). The mean preoperative weight and BMI were 122.93 ± 17.76 (kg) and 45.67 ± 5.47 (kg/m2), respectively. The prevalence of IGT, T2DM, hypertension, dyslipidemia, and hypothyroidism were 17.4%, 18.65%, 19.90, 40.31%, and 19.90%, respectively. Further, 17.99% and 53.79% of participants suffered from sleep apnea and low-back and knee pain. In addition, 3.23% of patients had a history of cardiovascular disease (Table 1).

Table 1.

Characteristics of the patients

CharacteristicsRYGBOAGBLSGp value
N = 870N = 1,381N = 316
Age, years, mean±SD 40.16±10.45 39.34±10.85 37.61±10.33 0.121 
Preoperative weight, kg, mean±SD 120.22±18.76 125.7±6.5 122.87±23.23 <0.001 
Preoperative BMI, kg/m2, mean±SD 45.05±5.2 46.56±6.5 45.4±6.47 <0.001 
Sex (female), N (%) 727 (83.6) 1,081 (78.3) 249 (78.8) 0.008 
BMI, N (%), <50 728 (84) 1,000 (72.5) 260 (82.3) <0.001 
Comorbidities, N (%) 
 Hypertension 178 (20.5) 279 (20) 54 (17) 0.4 
 T2DM 134 (15.5) 324 (23.5) 21 (6.6) <0.001 
 IGT 179 (20.6) 219 (16) 50 (15.8) 0.012 
 Dyslipidemia 375 (43) 558 (40.4) 102 (32.3) 0.004 
 Hypothyroidism 171 (19.7) 281 (20.3) 59 (18.7) 0.77 
 Low-back and knee pain 488 (56) 834 (60.5) 59 (18.7) 0.14 
 Sleep apnea 127 (14.6) 167 (12) 168 (53) 0.115 
 Cardiovascular disease 37 (4.3) 40 (3) 6 (1.9) 0.075 
CharacteristicsRYGBOAGBLSGp value
N = 870N = 1,381N = 316
Age, years, mean±SD 40.16±10.45 39.34±10.85 37.61±10.33 0.121 
Preoperative weight, kg, mean±SD 120.22±18.76 125.7±6.5 122.87±23.23 <0.001 
Preoperative BMI, kg/m2, mean±SD 45.05±5.2 46.56±6.5 45.4±6.47 <0.001 
Sex (female), N (%) 727 (83.6) 1,081 (78.3) 249 (78.8) 0.008 
BMI, N (%), <50 728 (84) 1,000 (72.5) 260 (82.3) <0.001 
Comorbidities, N (%) 
 Hypertension 178 (20.5) 279 (20) 54 (17) 0.4 
 T2DM 134 (15.5) 324 (23.5) 21 (6.6) <0.001 
 IGT 179 (20.6) 219 (16) 50 (15.8) 0.012 
 Dyslipidemia 375 (43) 558 (40.4) 102 (32.3) 0.004 
 Hypothyroidism 171 (19.7) 281 (20.3) 59 (18.7) 0.77 
 Low-back and knee pain 488 (56) 834 (60.5) 59 (18.7) 0.14 
 Sleep apnea 127 (14.6) 167 (12) 168 (53) 0.115 
 Cardiovascular disease 37 (4.3) 40 (3) 6 (1.9) 0.075 

BMI, body mass index; T2DM, type 2 diabetes mellitus; IGT, impaired glucose tolerance; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Weight Loss Trend in Three Surgery Types

The mean values of %EWL at 6 months after each procedure were comparable, and mean differences were not statistically significant (65%, 62%, and 63% EWL for OAGB, RYGB, and LSG, respectively, p = 0.468). At 9 months after surgery, OAGB represented a significantly higher %EWL than RYGB and LSG (76%, 71%, and 71% respectively, p < 0.001). RYGB and LSG did not show a significant difference in weight loss trend until 24 months after surgery. 24 months postoperatively, RYGB illustrated a significantly higher %EWL respect to LSG (77% vs. 71%, p < 0.001) (Table 2). At 3 months after surgery, OAGB represented a significantly higher %TWL than RYGB and LSG (20.83%, 19.87%, and 19.9% respectively, p < 0.001) (Table 3). The number of included participants in each time point is reported in Tables 2 and 3.

Table 2.

%EWL of the patients at the different time points after surgery

%EWL, mean±SD
Time point, month (n)RYGBOAGBLSGp value
N = 870N = 1,381N = 316
1 (2,567) 25.95±10.77 25.07±10.05 25.60±9.527 0.882 
3 (2,552) 46.45±13.84 47.15±13.32 46.89±13.77 0.106 
6 (2,538) 62.52±16.69 65.39±15.92 63.49±18.34 0.468 
9 (2,516) 71.38±17.70a 76.24±17.39b 71.86±19.43a <0.001 
12 (2,503) 76.40±19.18a 81.94±18.22b 73.82±21.34a <0.001 
18 (2,452) 78.46±20.44a 85.79±19.12b 75.33±24.12a <0.001 
24 (2,368) 77.44±20.75a 85.54±19.43b 71.60±24.31c <0.001 
36 (2,129) 73.28±21.54a 82.01±21.09b 68.86±24.99a <0.001 
48 (1,872) 69.44±22.28a 80.18±19.01b 60.06±25.94c <0.001 
60 (1,683) 65.55±23.76a 77.60±16.95b 57.10±26.68a <0.001 
%EWL, mean±SD
Time point, month (n)RYGBOAGBLSGp value
N = 870N = 1,381N = 316
1 (2,567) 25.95±10.77 25.07±10.05 25.60±9.527 0.882 
3 (2,552) 46.45±13.84 47.15±13.32 46.89±13.77 0.106 
6 (2,538) 62.52±16.69 65.39±15.92 63.49±18.34 0.468 
9 (2,516) 71.38±17.70a 76.24±17.39b 71.86±19.43a <0.001 
12 (2,503) 76.40±19.18a 81.94±18.22b 73.82±21.34a <0.001 
18 (2,452) 78.46±20.44a 85.79±19.12b 75.33±24.12a <0.001 
24 (2,368) 77.44±20.75a 85.54±19.43b 71.60±24.31c <0.001 
36 (2,129) 73.28±21.54a 82.01±21.09b 68.86±24.99a <0.001 
48 (1,872) 69.44±22.28a 80.18±19.01b 60.06±25.94c <0.001 
60 (1,683) 65.55±23.76a 77.60±16.95b 57.10±26.68a <0.001 

%EWL, percentage of excess weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Different letters (a, b, c) show significant differences between each pairwise surgery types, according to Tukey’s test.

Table 3.

%TWL of the patients at different time points after surgery

%TWL, mean±SD
Time point, month (n)RYGBOAGBLSGp value
N = 870N = 1,381N = 316
1 (2,567) 11.12±3.85a 11.09±3.69 10.84±3.54 0.44 
3 (2,552) 19.87±4.85a 20.83±4.43b 19.90±4.72a <0.001 
6 (2,538) 26.84±5.86a 28.95±5.26b 27.12±6.31a <0.001 
9 (2,516) 30.88±6.56a 33.73±6.13b 30.86±6.85a <0.001 
12 (2,503) 33.30±7.53a 36.26±6.88b 32.00±8.09c <0.001 
18 (2,452) 34.44±8.29a 37.95±7.56b 33.05±9.21c <0.001 
24 (2,368) 34.06±8.54a 37.62±7.98b 32.22±9.83c <0.001 
36 (2,129) 32.37±9.15a 36.05±8.78b 31.16±10.5a <0.001 
48 (1,872) 30.69±9.53a 35.61±8.39b 27.61±11.7c <0.001 
60 (1,683) 29.14±9.94a 34.64±8.37b 26.17±12.4a <0.001 
%TWL, mean±SD
Time point, month (n)RYGBOAGBLSGp value
N = 870N = 1,381N = 316
1 (2,567) 11.12±3.85a 11.09±3.69 10.84±3.54 0.44 
3 (2,552) 19.87±4.85a 20.83±4.43b 19.90±4.72a <0.001 
6 (2,538) 26.84±5.86a 28.95±5.26b 27.12±6.31a <0.001 
9 (2,516) 30.88±6.56a 33.73±6.13b 30.86±6.85a <0.001 
12 (2,503) 33.30±7.53a 36.26±6.88b 32.00±8.09c <0.001 
18 (2,452) 34.44±8.29a 37.95±7.56b 33.05±9.21c <0.001 
24 (2,368) 34.06±8.54a 37.62±7.98b 32.22±9.83c <0.001 
36 (2,129) 32.37±9.15a 36.05±8.78b 31.16±10.5a <0.001 
48 (1,872) 30.69±9.53a 35.61±8.39b 27.61±11.7c <0.001 
60 (1,683) 29.14±9.94a 34.64±8.37b 26.17±12.4a <0.001 

%TWL, percentage of total weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Different letters (a, b, c) show significant differences between each pairwise surgery types, according to Tukey’s test.

Key Time Points of Weight Loss Plateau in Three Surgery Types

The maximum %EWL and %TWL for 5 years postoperative was obtained in 18th month after all three types of OAGB, RYGB, and LSG. The time of 18 months following surgery was the most probable time point for initiation of weight loss plateau (Table 3).

Weight Regain Critical Times in Three Surgery Types

In 18 months after surgery, LSG showed significantly weight regain rather than other types of surgery. The most weight regain in three procedures were taken place in 36–48 months’ interval post-surgery. The total 5-years weight regains in three procedures (6.88%, 5.3%, and 3.3% for LSG, RYGB, and OAGB, respectively) were significantly different.

The Assessment of Five-Year Weight Loss after Surgery

From a total of 2,567 participants of the present retrospective cohort study, the 5-year follow up rates were 85% (n = 268), 81% (n = 704), and 78% (n = 1,077) for LSG, RYGB, and OAGB; respectively. The 5-year %EWL and %TWL trend revealed several weight fluctuations from the time of surgery. This trend was significantly different among the three types of surgery (p < 0.001) (Fig. 1). The mean %EWL/%TWL, 5 years post-LSG was almost comparable to the amount of weight loss in 6 months’ post-surgery. Further, the 5-year mean weight loss after RYGB was equal to the %TWL which was obtained in 9 months following surgery. In addition, for OAGB, 5-year mean %EWL was comparable to %EWL in 12 months’ post OAGB surgery. Accordingly, the mean %WL in 6, 9, and 12 months after LSG, RYGB, and OAGB, respectively, could predict the %WL outcome 5 years’ post-surgery (Fig. 2).

Fig. 1.

The 5-year trend of mean %TWL of the patients in three surgery types. %TWL, percentage of total weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Fig. 1.

The 5-year trend of mean %TWL of the patients in three surgery types. %TWL, percentage of total weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Close modal
Fig. 2.

The 5-year trend of mean %EWL of the patients in three surgery types. %EWL, percentage of excess weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Fig. 2.

The 5-year trend of mean %EWL of the patients in three surgery types. %EWL, percentage of excess weight loss; RYGB, Roux-en-Y gastric bypass; OAGB, one-anastomose gastric bypass; LSG, laparoscopic sleeve gastrectomy.

Close modal

The results of the present study showed that the mean %EWL in the first 6 months after surgery was independent of the type of surgery and was similar in different surgeries. OAGB and RYGB induced weight loss speed up after nine and 24 months (respectively) as compared to LSG. Weight plateau and weight regain occurred earlier and higher in LSG during 5 years. The 5 years %WL could be comparable with %WL in 6, 9, and 12 months after LSG, RYGB, and OAGB, respectively.

Based on the findings of this study, OAGB creates the fastest and highest %EWL which is followed by RYGB and LSG in the 5-year %EWL trend. The results of prospective randomized comparative studies of short- and long-term weight loss were in line with our study [9]. Their findings showed that OAGB yields a significantly greater %TWL than RYGB and LSG at 1, 2, and 5 years after surgery. However, they did not find significant %TWL differences between RYGB and LSG in the short- and long-term [10]. Based on another study to compare the effects of the LSG and RYGB based on a meta-analysis of 28 articles, the pooled analysis of 3-year and 5-year follow-up revealed that RYGB had a significant advantage over LSG for the %EWL as well as remission of T2DM. [11‒13]. So, these differences in weight reduction of various types of surgery should be considered in the patient selection and choice of suitable type of surgery [14]. It seems that a subset of bariatric patients fails to maintain their weight loss and may struggle with weight loss plateau or weight regain [15]. Several studies suggested that approximately 50% of patients may experience weight loss plateau. In addition, at least 10–30% of patients regain their weight as early as 18–24 months’ post-surgery [16, 17]. The results of the present study support the finding of previous studies that the time interval of 18–24 months after operations is the most probable time to hitting in weight loss plateau and even weight regain, especially for LSG, which induces the earliest and highest weight regain during 5-year follow-up after surgery. In LSG, as a restrictive procedure, expanding sleeved stomach caused by dietary failure or unmodified feeding behavior was the most common cause of weight loss resistance and/or weight regain. Other factors that influence weight regain after surgery include the presence of binge-eating disorders [16, 18]. Obesity comorbidities often return with weight regain [19]. Furthermore, its management is difficult with the dietary approach or lifestyle modification alone [17, 20]. Previous studies have found that among patients experiencing weight loss resistance or weight regain, 60% never adopted nutritional follow-up and 80% never passed psychological follow-up [21]. So, the prevention of weight regains and weight loss plateau are suggested as the first therapeutic step which is possible when the patient and surgeon team are aware of the common risk factors and most probable times when the weight loss speeds down and/or weight could relapse.

The 5-year %TWL after surgery was predictable by %TWL in 3–6, 6–9, and 9–12 months after LSG, RYGB, and OAGB, respectively. The present findings were comparable with the results of the Manning et al. [22] study. They showed that the percentage of weight loss 3–6 months after LSG and RYGB was an independent predictor of maximal %TWL [23]. Another prospective study of %EWL trend revealed that early weight loss trend could predict the mid-term 3-year outcome of patient underwent RYGB [24, 25]. Various factors, including gender, age, preoperative weight, in addition to the patient’s orientation, are determined to affect long-term weight loss and outcomes of bariatric surgeries [26]. Many previous studies on long-term weight loss prediction after bariatric surgery generally suggest that the status of early response to bariatric surgery could determine the long-term weight loss expectation. The present finding suggests that early postoperative weight loss can be used to predict mid-term outcomes after bariatric surgeries. It provides the opportunity for early identification of patient’s suboptimal weight loss which could allow earlier consideration of intensive postoperative lifestyle and/or behavioral modification to enhance their maximum long-term weight loss. The examples include regular and tighter nutritional and psychological follow-up visits to modify emotional eating, graze eating, irregular frequent snaking, sweet/high-calorie eating, as well as uncontrolled psychological disorders and life stressors plus lack of regular physical activity.

Some strengths of the present study included reasonably large sample size, mid-term follow-up of post-operative patients. Using data from a nationwide referral center of obesity surgery registry could assure the generalizability of our findings. Further, the comparison of outcomes between the three most popular types of surgeries contributes to the most appropriate individualized selection of types of surgeries. Retrospective design of the study could be a study limitation. Prospective multicenter large studies with longer follow-up, controlling for nutritional regimens, physical activity, weight-related medications, compliance with these regimens, and medications are suggested to be conducted in future studies.

The longer term result of surgery remains one of the most important concerns of patients and the bariatric surgery team. OAGB provides the fastest and highest %EWL/TWL, while LSG induced the earliest and largest weight plateau plus weight regain during 5 years’ post-surgery. The pattern of early weight loss could predict the mid-term outcome of bariatric surgery. So, early identification of patient’s suboptimal weight loss could allow consideration of earlier intensive postoperative lifestyle and/or behavioral modification to enhance their maximum long-term weight loss.

The present project was approved by the Ethics Committee of Iran University of Medical Sciences with the ID number of IR.IUMS.REC 1395.95-04-140-29239. Written informed consent was obtained from all individual participants included in the study.

The authors declared no conflicts of interest regarding the publication of the present article.

No funding was obtained for this study.

Mahsa Hatami: conceptualization, data collection, writing original draft, and review and editing of final draft. Abdolreza Pazouki: conceptualization, supervision, data collection, and review and editing of final draft. Fatemeh Sadat Hosseini-Baharanchi: conceptualization, writing original draft, methodology and analysis, and review and editing of final draft. Ali Kabir: conceptualization, supervision, methodology and analysis, and review and editing of final draft.

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

1.
O’Kane
M
,
Parretti
HM
,
Pinkney
J
,
Welbourn
R
,
Hughes
CA
,
Mok
J
.
British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update
.
Obes Rev
.
2020
;
21
(
11
):
e13087
.
2.
Welbourn
R
,
Hollyman
M
,
Kinsman
R
,
Dixon
J
,
Liem
R
,
Ottosson
J
.
Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018
.
Obes Surg
.
2019
;
29
(
3
):
782
95
.
3.
Guerreiro
V
,
Neves
JS
,
Salazar
D
,
Ferreira
MJ
,
Oliveira
SC
,
Souteiro
P
.
Long-term weight loss and metabolic syndrome remission after bariatric surgery: the effect of sex, age, metabolic parameters and surgical technique: a 4-year follow-up study
.
Obes Facts
.
2019
;
12
(
6
):
639
52
.
4.
Ibrahim
AM
,
Ghaferi
AA
,
Thumma
JR
,
Dimick
JB
.
Variation in outcomes at bariatric surgery centers of excellence
.
JAMA Surg
.
2017
;
152
(
7
):
629
36
.
5.
Kornyushin
OV
,
Bakhtyukov
AA
,
Zorina
II
,
Toropova
YG
,
Derkach
KV
,
Berko
OM
.
[The effect of different types of bariatric surgery on the metabolic and hormonal parameters in rats with decompensed form of type 2 diabetes mellitus]
.
Adv Gerontol
.
2019
32
1–2
85
92
.
6.
Amundsen
T
,
Strømmen
M
,
Martins
C
.
Suboptimal weight loss and weight regain after gastric bypass surgery-postoperative status of energy intake, eating behavior, physical activity, and psychometrics
.
Obes Surg
.
2017
;
27
(
5
):
1316
23
.
7.
McGrice
M
,
Don Paul
K
.
Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions
.
Diabetes Metab Syndr Obes
.
2015
;
8
:
263
74
.
8.
Cooper
TC
,
Simmons
EB
,
Webb
K
,
Burns
JL
,
Kushner
RF
.
Trends in weight regain following roux-en-Y gastric bypass (RYGB) bariatric surgery
.
Obes Surg
.
2015
;
25
(
8
):
1474
81
.
9.
Muller
KE
,
Barton
CN
.
Approximate power for repeated-measures ANOVA lacking sphericity
.
J Am Stat Assoc
.
1989
;
84
(
406
):
549
55
.
10.
Lee
WJ
,
Almalki
OM
,
Ser
KH
,
Chen
JC
,
Lee
YC
.
Randomized controlled trial of one anastomosis gastric bypass versus roux-en-Y gastric bypass for obesity: comparison of the YOMEGA and taiwan studies
.
Obes Surg
.
2019
;
29
(
9
):
3047
53
.
11.
Gu
L
,
Huang
X
,
Li
S
,
Mao
D
,
Shen
Z
,
Khadaroo
PA
.
A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass
.
BMC Surg
.
2020
;
20
(
1
):
30
.
12.
Ignat
M
,
Vix
M
,
Imad
I
,
D’Urso
A
,
Perretta
S
,
Marescaux
J
.
Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss
.
Br J Surg
.
2017
;
104
(
3
):
248
56
.
13.
Zhang
Y
,
Zhao
H
,
Cao
Z
,
Sun
X
,
Zhang
C
,
Cai
W
.
A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome
.
Obes Surg
.
2014
;
24
(
10
):
1617
24
.
14.
Halpern
B
,
Mancini
MC
.
Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified
.
Acta Diabetol
.
2021
;
58
(
4
):
531
6
.
15.
Toth
AT
,
Gomez
G
,
Shukla
AP
,
Pratt
JS
,
Cena
H
,
Biino
G
.
Weight loss medications in young adults after bariatric surgery for weight regain or inadequate weight loss: a multi-center study
.
Children
.
2018
;
5
(
9
):
116
.
16.
Magro
DO
,
Geloneze
B
,
Delfini
R
,
Pareja
BC
,
Callejas
F
,
Pareja
JC
.
Long-term weight regain after gastric bypass: a 5-year prospective study
.
Obes Surg
.
2008
;
18
(
6
):
648
51
.
17.
Schwartz
J
,
Chaudhry
UI
,
Suzo
A
,
Durkin
N
,
Wehr
AM
,
Foreman
KS
.
Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review
.
Obes Surg
.
2016
;
26
(
2
):
452
8
.
18.
Malone
M
,
Alger-Mayer
S
.
Binge status and quality of life after gastric bypass surgery: a one-year study
.
Obes Res
.
2004
;
12
(
3
):
473
81
.
19.
Neto
RML
,
Herbella
FA
,
Tauil
RM
,
Silva
FS
,
de Lima
SE
.
Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain
.
Obes Surg
.
2012
;
22
(
10
):
1580
5
.
20.
Brethauer
SA
,
Kothari
S
,
Sudan
R
,
Williams
B
,
English
WJ
,
Brengman
M
.
Systematic review on reoperative bariatric surgery: American society for metabolic and bariatric surgery revision task force
.
Surg Obes Relat Dis
.
2014
;
10
(
5
):
952
72
.
21.
Panigrahi
ER
The impact of diet and psychosocial factors post bariatric surgery
.
2019
.
22.
Manning
S
,
Pucci
A
,
Carter
NC
,
Elkalaawy
M
,
Querci
G
,
Magno
S
.
Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass
.
Surg Endosc
.
2015
;
29
(
6
):
1484
91
.
23.
Philouze
G
,
Voitellier
E
,
Lacaze
L
,
Huet
E
,
Gancel
A
,
Prévost
G
.
Excess body mass index loss at 3 months: a predictive factor of long-term result after sleeve gastrectomy
.
J Obes
.
2017
;
2017
:
2107157
.
24.
Mor
A
,
Sharp
L
,
Portenier
D
,
Sudan
R
,
Torquati
A
.
Weight loss at first postoperative visit predicts long-term outcome of Roux-en-Y gastric bypass using duke weight loss surgery chart
.
Surg Obes Relat Dis
.
2012
;
8
(
5
):
556
60
.
25.
Lanyon
RI
,
Maxwell
BM
,
Kraft
AJ
.
Prediction of long-term outcome after gastric bypass surgery
.
Obes Surg
.
2009
;
19
(
4
):
439
45
.
26.
Seyssel
K
,
Suter
M
,
Pattou
F
,
Caiazzo
R
,
Verkindt
H
,
Raverdy
V
.
A predictive model of weight loss after roux-en-Y gastric bypass up to 5 years after surgery: a useful tool to select and manage candidates to bariatric surgery
.
Obes Surg
.
2018
;
28
(
11
):
3393
9
.